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Abstract: Primary Castleman’s disease of the chest wall is unusual.
Furthermore, such tumors arising from a surgical wound are ex-
tremely rare. We report a 33-year-old female with a history of a
thoracic surgery at 5 years of age. A round, homogenous 4 3.5-cm
mass protruded into the thoracic cavity on the posterior portion of
the previous posterolateral incision. The tumor was completely
removed, with combined rib resection. The resected specimen
showed Angiofollicular Lymph Node Hyperplasia (Castleman’s
disease), hyaline-vascular type. No recurrence has been found for 10
years. This is the first report of primary chest wall Castleman’s
disease arising from the surgical wound.
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Primary Castleman’s disease (CD) of the chest wall isunusual.1 We report an extremely rare case of Angiofol-
licular Lymph Node Hyperplasia (CD) arising from a surgical
wound of the chest wall. In addition, we discuss the etiology
and treatment of CD.
CASE REPORT
A 33-year-old female was referred to our hospital for a
2-month history of left shoulder pain. She had undergone
closure of a patent ductus arteriosus through posterolateral
incision at the age of 5 years. Chest radiograph showed a
round, homogenous 4  3.5-cm mass with sharp margin in
the left upper lung field (Figure 1). Chest computed tomog-
raphy showed homogenous soft-tissue-attenuating mass with
sharp margin (Figure 2). We performed a thoracotomy
through the fifth intercostal space, following left posterolat-
eral incision. Dense adhesion was found between the lung
and posterior parietal pleura at the level of the third and
fourth ribs, which corresponded to the previous surgical
wound. A hen’s egg-sized elastic hard mass was palpable
through the corresponding lung. Adhesion between the tumor
and the visceral pleura of the lung was released, and the
tumor was completely removed with combined resection of
the third and fourth ribs. The patient experienced no postop-
erative complication and has been followed up for 10 years
without relapse.
On gross examination, the tumor was found to be an
encapsulated brown mass measuring 3.5  4.0  3.0 cm,
stuck into the intercostal space. Sectioning of the mass
revealed a yellow solid surface, without invasion to surround-
ing tissue (Figure 3). Microscopic features showed the pres-
ence of numerous germinal centers interspersed in a popula-
tion of mononuclear cells and numerous capillaries without
sinusoid (Figure 4). At the germinal center, a small vessel
with a thickened, hyalinized wall extended into the midpor-
tion. These appearances were consistent with Angiofollicular
Lymph Node Hyperplasia (CD), hyaline-vascular type, orig-
inating from the chest wall.
Comment
CD, Angiofollicular Lymph Node Hyperplasia, is one
of the atypical lymphoproliferative diseases. CD located in
the chest wall is rare; only, 11 cases have been reported in the
English and French literature.1 Furthermore, there have been
no cases arising from surgical wounds. We report here an
exceedingly rare case of CD arising from a surgical wound of
the chest wall.
CD is classified into unicentric and multicentric on the
basis of clinical appearance2 and into hyaline-vascular type
and plasma cell type on the basis of microscopic manifesta-
tion.3 Most CD located in the chest wall are unicentric and
hyaline-vascular type.1 Like most cases, ours was unicentric
and hyaline-vascular type.
The etiology of CD is unknown, although several
theories have been presented. Chronic inflammation, hamar-
tomatous process, immunodeficiency state, and autoimmunity
have been proposed as etiologies of this disease.4 In multi-
centric CD, Kaposi sarcoma-associated herpesvirus is related
to its tumorigenesis.5 We here demonstrate a case of CD
arising from a surgical wound. Gilliam and Woods6 pointed
out that lymphoid hyperplasia, including CD, might represent
exaggerated reactions to diverse external antigens including
trauma in the skin. In our patient, the wound stimuli such as
remnant thread or infection around the wound, might have
been a pathogenesis of CD.
Surgery is essential for unicentric type CD. Bowne et
al.4 reported that complete surgical resection in 10 unicentric
CD patients achieved no recurrence at least for 9 to 37
months. We successfully treated our patient with complete
resection, and have observed no complications or relapses
until now. However, those authors pointed out that partial
resection, radiotherapy or observation alone might be an
alternative to complete resection, since three patients with
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remnant lesion remained asymptomatic for at least 12
months. Neuhof and Debus7 reported that 4 of 5 unicentric
CD patients were successfully treated with radiation. Radia-
tion may be another treatment option. Multicentric CD is
defined as a systemic disease. Many such patients have a poor
prognosis, though multimodality therapy including radiother-
apy and chemotherapy have been administered.5 Recently, a
unicentric, non-HIV-associated hyaline–vascular type CD pa-
tient was successfully treated with anti-CD20 therapy.8 This
may be another alternative therapy for tumor not completely
resected.
We demonstrate a case of CD arising from a surgical
wound of the chest wall, and suggest that its etiology might
be the surgical wound. We believe that this is the first report
in the literature of CD arising from the surgical wound.
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FIGURE 1. Posteroanterior chest radiograph demonstrating
homogenous tumor close to deformed third rib of left chest
wall.
FIGURE 2. Chest computed tomography demonstrating
homogenous soft-tissue-attenuating mass with sharp margin.
FIGURE 3. Macroscopic appearance of oval solid tumor
with chest wall. Tumor was encapsulated and did not invade
surrounding tissues.
FIGURE 4. Microscopic appearance of resected tumor
(Haematoxylin and Eosin [HE], 80). Hyperplastic lym-
phoid follicle has small hyaline vascular structure and is
surrounded by cuff of small lymphocytes in concentric
“onion skin” layers.
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